Treatment of dyspnoea in patients receiving palliative care: Nasal delivery of oxygen compared with opioid adminstration;Symptomatische therapie der dyspnoe bei patienten in der palliativmedizin: Sauerstoff-insufflation versus opioidapplikation

Deutsche Medizinische Wochenschrift

Volumn 132, Issue 38, 2007, Pages 1939-1943

  Clemens, Katri Elena ^a,b   Klaschik, E ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b Malteser Krankenhaus Bonn/Rhein Sieg   (Germany)

Author keywords

Dyspnoea; Morphine; Nasal oxygen; Opioids; Palliative care

Indexed keywords

DIHYDROMORPHINE; MORPHINE; HYDROMORPHONE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER THERAPY; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DYSPNEA; FEMALE; HUMAN; MALE; OXYGEN THERAPY; PALLIATIVE THERAPY; TREATMENT OUTCOME; BREATHING; COMPARATIVE STUDY; DRUG EFFECT; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; NEOPLASM; PROSPECTIVE STUDY; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DYSPNEA; FEMALE; HUMANS; HYDROMORPHONE; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; OXYGEN INHALATION THERAPY; PALLIATIVE CARE; PROSPECTIVE STUDIES; RESPIRATION; SEVERITY OF ILLNESS INDEX;

EID: 34548605292     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985621     Document Type: Article

References (29)

1. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003; 327: 523-528
2. Ahmedzai S. Oxford Textbook of palliative medicine. 2nd ed. Palliation of respiratory symptoms. In: Doyle D, Hanks GWC, MacDonald N, eds, Oxford Medical Publications, Oxford: 1998: 583-616
3. Anonymus. Dyspnea. Mechanism, assessment, and management: a consensus statement. American Thoracic Society Position Statement. Am J Respir Crit Care Med 1999; 159: 321-40
4. Bourke DL, Warley A. The steady state and breathing methods compared during morphine administration in humans. Journal of Physiology 1989; 419: 509-517
5. Boyd KJ, Kelly M. Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer. Palliative Medicine 1997; 11: 277-281
6. Bruera E, MacEachern T, Ripamonti C, Hanson J. Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med 1993; 119: 906-907
7. Bruera E, Macmillan K, Pither J, MacDonald RN. Effects of morphine on the dyspnoea of terminal cancer patients. J Pain Symptom Manage 1990(65: 341-4
8. Bruera E, Sweeny C, Willey J et al. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnoea. Palliative Medicine 2003; 17: 659-663
9. de Conno F, Spoldi E, Caraceni A, Ventafridda V. Does pharmacological treatment affect the sensation of breathlessness in terminal cancer patients? Palliative Medicine 1991; 5: 237-243
10. Cuvelier A, Grigoriu B, Molano LC, Muir JF. Limitations of transcutaneous Chest 2005; 127: 1744-48
11. Florez J, Mediavilla A. Respiratory and cardiovascular effects of metenkephalin applied to the ventral surface of the brain stem. Brain Res 1978; 138: 585-590
12. Freye E. Opioide in der Medizin. Wirkung und Einsatzgebiete zentraler Analgetika. Wünschenswerte Effekte und Nebenwirkungen der Opioide. In: Freye E (Hrsg). 4. Auflage. Springer, Berlin, Heidelberg, New York: 1998: 64-70
13. Gugger M, Bachofen H. Dyspnoe, Grundlagen und Pathophysiologie. Schweiz Med Forum 2001; Nr. 6
14. Heyse-Moore LH, Ross V, Mullee MA. How much of a problem is dyspnoea in advanced cancer? Palliative Medicine 1991; 5: 20-26
15. Higginson IJ, Mc Carthy M. Measuring symptoms in terminal cancer: are pain and dyspnoea controllled? J Roy Soc Med 1989; 82: 264-267
16. Jennings AL, Davids AN, Higgins JPT et al. Opioids for the palliation of breathlessness in terminal illness (Cochrane Review). In: The Cochrane Library, Update Software, Oxford: 2002; Issue 1
17. Jennings AL, Davies AN, Higgins JPT, Gibbs JSR, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002; 57: 939-944
18. Klaschik E. Palliativmedizin. Dyspnoe. In: Husebø S, Klaschik E (Hrsg). Aktualisierte, 4. Auflage. Springer, Berlin, Heidelberg, New York: 2006: 276-279
19. Masford ML, Aranda S, Ashby M, Bowmann J, Brooksbank M, Cairns W et al. Therapeutic Guidelines Palliative Care, Version 1. Therapeutic guidelines limited, North Melbourne, Victoria, Australia: 2001
20. Moosavi SH, Golestanian E, Binks AP, Lansing RW, Brown R, Banzett RB. Hypoxic and hypercapnic drives to breathe generate equivalent levels of air hunger in humans. J Appl Physiol 2003; 94: 141-154
21. Muers MF. Opioids for Dyspnoea. Thorax 2002; 57: 922-923
22. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respiratory Care 2001; 46: 798-825
23. Philip J, Gold M, Milner A, Di Iulio J, Miller B, Spruyt O. A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer. J Pain Symptom Manage 2006; 32 (6): 541-50
24. Poole P, Veale AG, Black PN. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1877-1880
25. Schönhofer B, Suchi S, Haidl P, Köhler D. Eine "Epidemiologie" zum Stellenwert von oral appliziertem Morphium als Therapieform des schwergradigen Lungenemphysems vom Pink-Puffer-Typ. Medizinische Klinik 2001; 96: 325-30
26. Thomas JR, Gunten CF Von. Treatment of dyspnea in cancer patients. Oncology 2002; 16 (6): 745-50
27. Walsh TD. Opiates and respiratory function in advanced cancer. Recent Results Cancer Res 1984; 89: 115-17
28. Wilcock A. Handbook of palliative care. The Management of Respiratory Symptoms. In: Faull C, Carter Y, Woof R (eds), Blackwell, Oxford: 1998: 157-176
29. Wilson RH, Hoshet W, Dempsey ME. Respiratory acidosis: effects of decreasing respiratory minute volume in patients with chronic pulmonary emphysema, with specific reference to oxygen, morphine and barbiturates. Am J Med 1954; 18: 464-70